Three-year outcomes of phacogoniotomy versus phacotrabeculectomy for advanced primary angle-closure glaucoma with cataract: A randomized controlled trial
Asia-Pacific Journal of Ophthalmology · 2026-09 · 15 (5) · 100353
DOI: 10.1016/j.apjo.2026.100353 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Asia-Pacific Journal of Ophthalmology, 2026-09. Verfasst von Fengbin Lin und 35 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and …. Hauptthemen laut MEDLINE: Glaucoma, Angle-Closure, Trabeculectomy, Phacoemulsification, Intraocular Pressure. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
PURPOSE: To evaluate the 3-year efficacy and safety of phacogoniotomy versus phacotrabeculectomy for advanced primary angle-closure glaucoma (PACG) with cataract. DESIGN: Multicenter, randomized controlled, open-label, non-inferiority trial. METHODS: Patients were randomized 1:1 to undergo either phacogoniotomy (65 eyes) or phacotrabeculectomy (59 eyes). Three years retention was 92.3% (60/65) and 83.1% (49/59) for each group, respectively. Primary outcome was 3-year intraocular pressure (IOP) reduction (noninferiority margin: 4 mmHg). Secondary outcomes included surgical success, complications, hypotensive medications used; additional outcomes were changes in visual acuity (BCVA), visual field (VF), and corneal endothelial cell density (ECD). RESULTS: At 3 years, phacogoniotomy reduced mean IOP from 40.2 (10.3) to 14.1 (2.4) mmHg (-26.1 [10.4] mmHg reduction); phacotrabeculectomy, from 39.7 (9.3) to 14.4 (2.5) mmHg (-25.3 [9.2] mmHg reduction). Adjusted between-group difference in IOP change was -0.37 mmHg (95% CI, -1.32-0.58 mmHg; P = 0.44), meeting noninferiority. Complete (78.3% vs 89.8%; P = 0.13) and qualified (90.0% vs 91.8%; P > 0.999) success rates were comparable. Hypotensive medications declined in both groups (phacogoniotomy: 2.1 [1.2] to 0.2 [0.6]; phacotrabeculectomy: 2.1 [1.3] to 0.0 [0.2]; P = 0.06 for 3-year difference). BCVA improvements (0.1 vs 0.0 logMAR; P = 0.49), VF stability (MD difference:1.42 dB, P = 0.26; PSD difference: 0.22 dB, P = 0.75), and ECD loss (difference: 2%; P = 0.53) were similar. No new complications occurred in extended follow-up. CONCLUSIONS: At 3 years, phacogoniotomy remained non-inferior to phacotrabeculectomy in IOP reduction for advanced PACG with cataract.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocul…
- Department of Ophthalmology, Shijiazhuang People's Hospital, Shijiazhuang, China.
- Handan City Eye Hospital (The Third Hospital of Handan), Handan, China; Handan First Hospital, Handan, China.
- Department of Ophthalmology, Fujian Medical University Union Hospital, Fuzhou, China.
- Department of Ophthalmology, the Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Handan City Eye Hospital (The Third Hospital of Handan), Handan, China.
Förderung
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Lin, F., Song, Y., Zhang, H., Fan, S., Xiao, M., Zhu, X., Yan, X., Li, X., Song, W., Tang, L., Wen, T., Tang, G., Yuan, H., Yang, Y., Xu, J., Zhan, X., Zhou, M., Zhao, X., Li, F., …, & PVP Study group (2026). Three-year outcomes of phacogoniotomy versus phacotrabeculectomy for advanced primary angle-closure glaucoma with cataract: A randomized controlled trial. Asia-Pacific Journal of Ophthalmology, 15(5), 100353. https://doi.org/10.1016/j.apjo.2026.100353
Vancouver
Lin F, Song Y, Zhang H, Fan S, Xiao M, Zhu X, et al. Three-year outcomes of phacogoniotomy versus phacotrabeculectomy for advanced primary angle-closure glaucoma with cataract: A randomized controlled trial. Asia-Pacific Journal of Ophthalmology. 2026;15(5):100353. doi:10.1016/j.apjo.2026.100353
BibTeX
@article{Lin2026,
author = {Lin, Fengbin and Song, Yunhe and Zhang, Hengli and Fan, Sujie and Xiao, Meichun and Zhu, Xiaomin and Yan, Xiaowei and Li, Xiaoyan and Song, Wulian and Tang, Li and Wen, Tingli and Tang, Guangxian and Yuan, Huiping and Yang, Yangfan and Xu, Jiangang and Zhan, Xin and Zhou, Minwen and Zhao, Xiaohuan and Li, Fei and Yang, Zefeng and Zhou, Fengqi and Wang, Zhenyu and Jin, Ling and Liang, Xiaohong and Chen, Weirong and Lam, Dennis S C and Wang, Ningli and Tham, Clement C and Barton, Keith and Park, Ki Ho and Aung, Tin and Xie, Lin and Lu, Lan and Weinreb, Robert N and Zhang, Xiulan and PVP Study group, PVP Study group},
title = {Three-year outcomes of phacogoniotomy versus phacotrabeculectomy for advanced primary angle-closure glaucoma with cataract: A randomized controlled trial},
journal = {Asia-Pacific Journal of Ophthalmology},
year = {2026},
volume = {15},
number = {5},
pages = {100353},
doi = {10.1016/j.apjo.2026.100353}
}
EUVIMED